Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Inactivated Simian Immunodeficiency Virus-Pulsed Autologous Fresh Blood Cells as an Immunotherapy Strategy
  2. Mason, R. D.; Alcantara, S.; Peut, V.; Loh, L.; Lifson, J. D.; De Rose, R.; Kent, S. J.
  3. Journal of Virology. 2009 83(3): 1501-1510.
  1. 2.   Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague
  2. Goodin, J. L.; Nellis, D. F.; Powell, B. S.; Vyas, V. V.; Enama, J. T.; Wang, L. C.; Clark, P. K.; Giardina, S. L.; Adamovicz, J. J.; Michiel, D. F.
  3. Protein Expression and Purification. 2007, May; 53(1): 63-79.
  1. 3.   Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag
  2. Zhao, J.; Voltan, R.; Peng, B.; vis-Warren, A.; Kalyanaraman, V. S.; Alvord, W. G.; Aldrich, K.; Bernasconi, D.; Butto, S.; Cafaro, A.; Ensoli, B.; Robert-Guroff, M.
  3. Virology. 2005, NOV 10; 342(1): 1-12.
  1. 4.   Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following Ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE
  2. Pinczewski, J.; Zhao, J.; Malkevitch, N.; Patterson, L. J.; Aldrich, K.; Alvord, W. G.; Robert-Guroff, M.
  3. Viral Immunology. 2005, SPR; 18(1): 236-243.
  1. 5.   Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles
  2. Willey, R. L.; Byrum, R.; Piatak, M.; Kim, Y. B.; Cho, M. W.; Rossio, J. L.; Bess, J.; Igarashi, T.; Endo, Y.; Arthur, L. O.; Lifson, J. D.; Martin, M. A.
  3. Journal of Virology. 2003 77(2): 1163-1174.
  1. 6.   Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 Gag by using DNA expression vectors that target Gag antigen to the secretory pathway
  2. Qiu, J. T.; Liu, B. D.; Tian, C. J.; Pavlakis, G. N.; Yu, X. F.
  3. Journal of Virology. 2000 74(13): 5997-6005.
  1. 7.   Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
  2. Robinson, H. L.; Montefiori, D. C.; Johnson, R. P.; Manson, K. H.; Kalish, M. L.; Lifson, J. D.; Rizvi, T. A.; Lu, S.; Hu, S. L.; Mazzara, G. P.; Panicali, D. L.; Herndon, J. G.; Glickman, R.; Candido, M. A.; Lydy, S. L.; Wyand, M. S.; McClure, H. M.
  3. Nature Medicine. 1999 5(5): 526-534.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel